PetMed Express (NASDAQ:PETS) Announces Earnings Results, Misses Estimates By $0.44 EPS

PetMed Express (NASDAQ:PETS - Get Free Report) issued its earnings results on Thursday. The company reported ($0.50) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.06) by ($0.44), FiscalAI reports. PetMed Express had a negative net margin of 28.22% and a negative return on equity of 40.26%. The business had revenue of $40.66 million for the quarter.Get PetMed Express alerts:PetMed Express Price PerformanceIs Petco Health & Wellness Out of the Doghouse on an EPS beat?NASDAQ PETS traded down $0.11 during trading on Thursday, reaching $2.98. The company's stock had a trading volume of 164,954 shares, compared to its average volume of 196,398. The firm has a fifty day moving average of $3.02 and a 200 day moving average of $2.85. PetMed Express has a one year low of $1.57 and a one year high of $5.57. The stock has a market capitalization of $63.68 million, a PE ratio of -1.12 and a beta of 0.70. Wall Street Analysts Forecast GrowthPETS has been the topic of a number of analyst reports. Wall Street Zen lowered PetMed Express from a "hold" rating to a "sell" rating in a research note on Saturday, October 18th. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of PetMed Express in a report on Monday, December 29th. One analyst has rated the stock with a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, the company has an average rating of "Sell" and an average target price of $3.20.Here’s The One Pet Stock That’s Not in the DoghouseCheck Out Our Latest Stock Report on PetMed ExpressInstitutional Investors Weigh In On PetMed ExpressA number of institutional investors and hedge funds have recently bought and sold shares of PETS. Bridgeway Capital Management LLC lifted its position in PetMed Express by 164.3% during the third quarter. Bridgeway Capital Management LLC now owns 107,816 shares of the company's stock valued at $271,000 after purchasing an additional 67,016 shares during the last quarter. CIBC Bancorp USA Inc. purchased a new stake in shares of PetMed Express during the 3rd quarter valued at $153,000. CIBC Private Wealth Group LLC bought a new stake in shares of PetMed Express during the 3rd quarter worth $75,000. Dimensional Fund Advisors LP grew its position in PetMed Express by 5.4% in the third quarter. Dimensional Fund Advisors LP now owns 481,517 shares of the company's stock worth $1,209,000 after acquiring an additional 24,624 shares in the last quarter. Finally, Oxford Asset Management LLP bought a new position in PetMed Express in the second quarter valued at $55,000. 73.33% of the stock is owned by hedge funds and other institutional investors. PetMed Express Company Profile (Get Free Report)One of these 5 Pet Care Stocks Can Be the Next Short SqueezePetMed Express, Inc operates as an online and catalog-based pet pharmacy and retail supplier under the 1-800-PetMeds brand name. The company distributes prescription and non‐prescription medications, nutritional supplements, flea and tick control products, and a range of pet health supplies directly to consumers. Through its licensed veterinary pharmacy in Delray Beach, Florida, PetMed Express fills orders for dogs, cats and other companion animals, offering both branded and generic products alongside its own private‐label formulations. Founded in 1996 by Marc Puleo, PetMed Express built its business on the premise of convenience and cost savings for pet owners seeking reliable access to veterinary medications.See AlsoFive stocks we like better than PetMed ExpressThe day the gold market brokeNEW LAW: Congress Approves Setup For Digital Dollar?What a Former CIA Agent Knows About the Coming CollapseYour Bank Account Is No Longer SafeBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyThis instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.Should You Invest $1,000 in PetMed Express Right Now?Before you consider PetMed Express, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PetMed Express wasn't on the list.While PetMed Express currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here